4
Changes in Ownership
Arcturus Therapeutics Holdings Inc. Filed Acc 0001209191-20-062733
Director sold 800,000 shares at an average $100.81 ($80,650,635)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. Director | 2020-12-08 | Sale | −442,255 | $105.54 | $46,675,593 | 2,557,745 | D |
| Ultragenyx Pharmaceutical Inc. Director | 2020-12-09 | Sale | −357,745 | $94.97 | $33,975,043 | 2,200,000 | D |
| Open-market sales · 800,000 sh · avg $100.81 · $80,650,635 | |||||||
Loading xslF345X03/doc4.xml…